Announcements
Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Original Research
Fibrinogen degradation products (F.D.P.) in ascitic fluid of patients affected by ovarian cancer
Show Less
1
Obstetric and Gynecological Clinic, University of Padua (Italy)
2
1st Medical Clinic, University of Padua (Italy)
Clin. Exp. Obstet. Gynecol. 1981, 8(2), 64–65;
Published: 10 June 1981
Abstract
Ascitic fluid samples from 10 patients with ovarian carcinoma and 10 with cirrhosis of the liver were examined for their content of components of the fibrinolytic system. Large amounts of fibrin/fibrinogen degradation products (F.D.P.) were found in the ascitic fluid in all patients with malignant tumors, but not in the other group. Determination of F.D.P. may therefore make it possible to differentiate between malignant and non-malignant ascitic fluid.